Related Experiment Videos
[Resistance associated with the glutathione system]
1CNRS URA 147 (département de pharmacotoxicologie et de pharmacogénétique), institut Gustave-Roussy, Villejuif, France.
Bulletin Du Cancer
|December 1, 1994
Summary
Drug resistance is a major challenge in cancer therapy. This study highlights the crucial roles of glutathione and glutathione-S-transferases in predicting patient response to chemotherapy, particularly alkylating agents.
Area of Science:
- Biochemistry and Molecular Biology
- Pharmacology
- Oncology
Context:
- Multiple drug resistance (MDR) mechanisms are known in various organisms.
- The P-glycoprotein (mdr1 gene product) mediates efflux of natural product drugs.
- Chemotherapy often utilizes alkylating agents that interact with glutathione.
Purpose:
- To investigate the role of glutathione and glutathione-S-transferases (GSTs) in chemotherapy resistance.
- To evaluate GST polymorphism as a prognostic factor for treatment response.
Summary:
- Alkylating agents, common in chemotherapy, react with glutathione via GSTs.
- This interaction suggests glutathione and GSTs are critical in overcoming drug resistance.
- Assessing GST polymorphism may predict patient outcomes with specific chemotherapies.
Impact:
- Provides insights into mechanisms of resistance to alkylating agents.
- Suggests potential biomarkers (glutathione levels, GST genotypes) for personalized chemotherapy.
- May guide the development of strategies to overcome drug resistance in cancer treatment.